Medicus Pharma Ltd. Files 2024 Annual Report Amendment

Ticker: MDCXW · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1997296

Sentiment: neutral

Topics: amendment, annual-report, pharmaceuticals

TL;DR

Medicus Pharma Ltd. filed an amendment to its 2024 10-K. Check for updates.

AI Summary

Medicus Pharma Ltd. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, incorporated in Ontario, Canada, with principal executive offices in W. Conshohocken, PA, is primarily involved in Pharmaceutical Preparations. This amendment was filed on April 30, 2025.

Why It Matters

This filing provides updated or corrected information for investors regarding Medicus Pharma Ltd.'s financial performance and business operations for the 2024 fiscal year.

Risk Assessment

Risk Level: low — This is a routine amendment to an annual report, not indicating new material risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of this 10-K/A filing?

This is an amendment (Amendment No. 1) to the annual report (10-K) for the fiscal year ended December 31, 2024, filed by Medicus Pharma Ltd.

What is Medicus Pharma Ltd.'s primary business?

Medicus Pharma Ltd. is primarily engaged in Pharmaceutical Preparations, as indicated by its Standard Industrial Classification code [2834].

When was this amendment filed?

This amendment was filed on April 30, 2025.

Where are Medicus Pharma Ltd.'s principal executive offices located?

The principal executive offices of Medicus Pharma Ltd. are located at 300 Conshohocken State Rd., Suite 200, W. Conshohocken, PA 19428.

What is the SEC file number for Medicus Pharma Ltd.?

The SEC file number for Medicus Pharma Ltd. is 001-42408.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding Medicus Pharma Ltd. (MDCXW).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing